These effects, together with a prior report demonstrating that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 support the thought of targeting ACKR3 as a novel method to modulate the opioid system, which could open new therapeutic avenues for opioid-related disorders. Disclaimer: The above is often a https://marlboroughe766yrr1.wikisona.com/user